Delivering a smoke-free future

Our current product portfolio primarily consists of cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products.

As of June 30, 2024,  38 percent of our total net revenues came from our smoke-free products.

By 2030, our ambition is to increase that figure to over two-thirds, with the ultimate goal of phasing out cigarettes completely. Leveraging our scientific expertise and technological capabilities, we are also committed to developing new products in the wellness and healthcare space.

Our progress toward a smoke-free future as of Q2 2024


1 As of June 30, 2024. 2 As of December 31, 2023. Important Note: This information should be read in conjunction with the Philip Morris International Inc. earnings release dated July 23, 2024, as well as the accompanying glossary of key terms, definitions, explanatory notes, select financial information and reconciliations of non-GAAP financial measures, both of which are available on our Investor Relations pages. “PMI” refers to Philip Morris International Inc. and its subsidiaries. 

Looking to invest in a smoke-free future?

img_pmi_investor_relations_overview_banner_v2

Investor Relations Overview

Learn more about investing in Philip Morris International.
Find out more

Our smoke-free products

IQOS ILUMA heated tobacco product

PMI's smoke-free products

Our ambition is to replace cigarettes with our growing portfolio of smoke-free products as soon as possible.
Find out more

FAQs

From company information and sustainability to careers and our smoke-free portfolio, we answer frequently asked questions.


Heated tobacco products FAQs

IQOS ILUMA heated tobacco product

Heated tobacco products | Frequently asked questions

Find out more about PMI's heated tobacco products, otherwise known as heat-not-burn products.
Read more